Stay updated with breaking news from Nasdaq Ortx. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
CHI Advisors LLC boosted its holdings in shares of Orchard Therapeutics plc (NASDAQ:ORTX – Free Report) by 1,529.6% in the third quarter, according to its most recent filing with the Securities and Exchange Commission. The firm owned 12,315,654 shares of the company’s stock after acquiring an additional 11,559,916 shares during the quarter. Orchard Therapeutics accounts […]
Orchard Therapeutics (NASDAQ:ORTX – Get Free Report) and Immatics (NASDAQ:IMTXW – Get Free Report) are both medical companies, but which is the superior investment? We will compare the two companies based on the strength of their profitability, earnings, risk, institutional ownership, valuation, analyst recommendations and dividends. Profitability This table compares Orchard Therapeutics and Immatics’ net […]
Three oral presentations and seven posters highlight transformative potential of HSC gene therapy and newborn screening to address severe neurometabolic...
Forefront Analytics LLC bought a new stake in Orchard Therapeutics plc (NASDAQ:ORTX – Free Report) during the third quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor bought 14,183 shares of the company’s stock, valued at approximately $110,000. Forefront Analytics LLC owned 0.06% […]
Forefront Analytics LLC bought a new stake in shares of Orchard Therapeutics plc (NASDAQ:ORTX – Free Report) in the 3rd quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The firm bought 14,183 shares of the company’s stock, valued at approximately $110,000. Other hedge funds have also recently bought and […]